Clinical Trial

Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation

Recruiting
View on ClinicalTrials.gov →
Summary
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-01-18; most recent amendment 2026-07-12.
Status change: Not Yet Recruiting → Recruiting 2022-06-11
Trial Details
NCT Number NCT05215197
Lead Sponsor Pamukkale University
Conditions Hearing Loss, Sensorineural
Enrollment 10 participants
Start Date 2022-01-31
Primary Completion 2028-12-01 (estimated)
Study Completion 2028-12-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-14